Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadyah Alayadhi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|April 23, 2025
Transient Hyperprolactinemia After a Single Low-Dose PRN Olanzapine ODT in a Low-Functioning Autistic BoyAhmed Naguy, Nadyah Alayadhi, Dalal Elsori, et al.
Psychopharmacology Bulletin|January 2, 2025
Early Positive Report of Viloxazine for a Child with Hyperkinetic AutismAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
The Primary Care Companion for CNS Disorders|April 10, 2026
Psychopharmacotherapy UpdatesAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
Asian Journal of Psychiatry|September 20, 2024
2024 FDA-approved psychotropic medications: A conspectusAhmed Naguy, Nadyah Alayadhi, Ali Al-Tajali, et al.
Asian Journal of Psychiatry|June 28, 2023
2023 FDA-approved psychotropic medicationsAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
Psychopharmacology Bulletin|September 12, 2024
Psychopharmacotherapy of Pica-<i>How Much Do We Know</i>?Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, et al.
Psychopharmacology Bulletin|March 6, 2023
Clinical Indications of Memantine in Psychiatry-Science or Art?Muhammad Aljuwaiser, Nadyah Alayadhi, Victoria Ozidu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|April 23, 2025
Transient Hyperprolactinemia After a Single Low-Dose PRN Olanzapine ODT in a Low-Functioning Autistic BoyAhmed Naguy, Nadyah Alayadhi, Dalal Elsori, et al.
Psychopharmacology Bulletin|January 2, 2025
Early Positive Report of Viloxazine for a Child with Hyperkinetic AutismAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
The Primary Care Companion for CNS Disorders|April 10, 2026
Psychopharmacotherapy UpdatesAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
Asian Journal of Psychiatry|September 20, 2024
2024 FDA-approved psychotropic medications: A conspectusAhmed Naguy, Nadyah Alayadhi, Ali Al-Tajali, et al.
Asian Journal of Psychiatry|June 28, 2023
2023 FDA-approved psychotropic medicationsAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.
Psychopharmacology Bulletin|September 12, 2024
Psychopharmacotherapy of Pica-<i>How Much Do We Know</i>?Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, et al.
Psychopharmacology Bulletin|March 6, 2023
Clinical Indications of Memantine in Psychiatry-Science or Art?Muhammad Aljuwaiser, Nadyah Alayadhi, Victoria Ozidu, et al.
Pageof 1